Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113

Human immunodeficiency virus–seronegative men aged 15–22 years who lost bone mineral density (BMD) during tenofovir disoproxil fumarate/emtricitabine preexposure prophylaxis (PrEP) showed BMD recovery 48 weeks following PrEP discontinuation. Lumbar spine and whole body BMD z-scores remained below ba...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Infect Dis
मुख्य लेखकों: Havens, Peter L, Perumean-Chaney, Suzanne E, Patki, Amit, Cofield, Stacey S, Wilson, Craig M, Liu, Nancy, Anderson, Peter L, Landovitz, Raphael J, Kapogiannis, Bill G, Hosek, Sybil G, Mulligan, Kathleen
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2020
विषय:
Brief Reports
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319267/
https://ncbi.nlm.nih.gov/pubmed/31179503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz486
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन